The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
about
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytesThe voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brainKv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cellsA C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.K+ channels as targets for specific immunomodulationThe intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humansEngineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesPhosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cellsKv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesTargeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitisIon channels and transporters in lymphocyte function and immunityComputational studies of marine toxins targeting ion channelsPreferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesLymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugsMultiple Sclerosis and T Lymphocytes: An Entangled StoryPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseasePotassium channels, memory T cells, and multiple sclerosisPotent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockersTargeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseasesThe antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blockerK(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthmaPeptidomimetic Star Polymers for Targeting Biological Ion ChannelsThe C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactinTASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system.Modeling and simulation of ion channels.The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.Study of membrane potential in T lymphocytes subpopulations using flow cytometry.Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthmaHelminth Immunomodulation in Autoimmune Disease.Selected microRNAs define cell fate determination of murine central memory CD8 T cells.Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitisKv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis.Autoimmune effector memory T cells: the bad and the goodA systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activationT-lymphocyte Kv1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patientsBinding modes of two scorpion toxins to the voltage-gated potassium channel kv1.3 revealed from molecular dynamics.Oxidative modulation of voltage-gated potassium channels.Natural products and ion channel pharmacology
P2860
Q21143901-63EA0C1E-9310-4AFF-885D-7993DF0694E9Q24534346-F7A4E5B7-F618-404D-8FBA-2A8F67379B22Q24608511-14B076FE-2AAC-4F56-9DB8-C96F47C511FEQ24614314-7397D21F-2E1B-4389-A669-2358AF10677BQ24646861-85583A7B-8AF4-42E1-8ECD-61F35C07A931Q24648323-644D4A79-6F04-40B1-A26F-A136635457CAQ24648765-023BB364-157A-44F2-9306-5C7BD0FDF2D0Q24657847-16B35402-1602-47BF-9BEA-196FE9C6CA89Q24671130-65A0B8A8-83D9-4C98-9C6F-2BEA1BCCE029Q24676659-6091C058-E4CD-44BB-96B3-50512310A97EQ24685784-E93B8DA9-82D6-4376-97EB-051B42AB2D27Q26829714-35E13B51-D4CC-4383-9842-B07FCEF09419Q26853268-1C504C33-DDD4-405F-A29C-5CAE12E4CA08Q27346374-EEA2BB98-9D6B-4967-A6B6-0A641BDE403DQ27684056-4F7FC6D2-412E-49C6-86F0-AA9242CF7A33Q28069399-3510DC8A-1529-414D-9D56-633D5D13A5AFQ28086853-E08999BD-CCAA-486D-B2E8-777C353220ECQ28252713-CA886539-E6F9-4092-A7E7-CE688963DDF8Q28281365-A87A2BB2-C924-4142-BBE0-62C8A7DD9CC6Q28294590-60B87C14-3AA0-40C6-9EB9-BCDF108C3BC6Q28303760-CE246E60-2BE7-4EE4-B600-4ED9789EDC37Q28482737-BD59FA5F-785D-4E52-89B9-4D9D07EDF0F0Q28534242-E7FC5650-D28D-4E12-A084-7F8327CEE7CFQ28550966-ED2BCADE-158D-4850-B572-FFB4D7833817Q30009211-F69E0A2B-CFE1-435B-BAB8-921A099C5FD7Q30433284-A06DA12C-31A3-4C5F-940A-D8A0ACBBE86DQ30443341-7881A03C-65CD-4130-A960-75A394D559FAQ30483756-38B914A3-46A8-4770-BCCF-E526349573B3Q33382263-594B25DF-70D2-40EF-8E3E-3A54F49CE3A7Q33556185-5A385D3B-BCD4-4BA5-80C3-A4225CA1F02EQ33593313-DA7FE397-76F2-4D6F-B75E-96E6BA663514Q33617726-341C790C-8BF1-41F1-844C-13D8E3584114Q33667663-69C6D147-F244-42F7-91B2-9CAEACFE534EQ33776820-D22C762E-0AC9-4453-9E1D-DEA811584B9DQ33794691-3F31B316-6FB6-4818-BFBC-F5C8F9507F22Q33837684-38F7F585-0637-480C-9F33-845285EA61ABQ33846973-7E181C3A-B356-4EEA-9EBD-D659CDE7334AQ33963182-B3B5E087-496F-4253-882B-3A2C8030F365Q33975038-759A010C-52CB-48DD-B781-BA8B8C6F5F1EQ34128527-2AADAFE2-8627-4E83-8BAA-7F307E53FAA7
P2860
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@ast
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@en
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@nl
type
label
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@ast
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@en
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@nl
prefLabel
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@ast
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@en
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@nl
P2093
P2860
P3181
P356
P1476
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS
@en
P2093
Christine Beeton
Heike Wulff
K George Chandy
Michael Pennington
Rameeza Allie
P2860
P304
P3181
P356
10.1172/JCI16921
P407
P577
2003-06-01T00:00:00Z